Mammalian Cell Lines and Glycosylation: A Case Study

Post-translational Modification of Protein Biopharmaceuticals

Volumn , Issue , 2009, Pages 51-77

  Butler, Michael ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Culture parameters; Functional glycomics; Glycan heterogeneity; Glycosylation; Immunogenicity; Mammalian cell lines

Indexed keywords

EID: 84889413132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527626601.ch3     Document Type: Chapter

References (113)

1. Butler, M. (2004) Animal Cell Culture and Technology, 2nd edn, Bios Scientific, Oxford.
2. Goto, M., Akai, K., Murakami, A., Hashimoto, C., Tsuda, E., Ueda, M., Kawanishi, G., Takahashi, N., Ishimoto, A., Chiba, H. and Sasaki, R. (1988) Production of recombinant human erythropoietin in mammalian cells: host-cell dependency of the biological activity of the cloned glycoprotein. Bio/Technology, 6, 67-71.
3. Goochee, C.F. (1992) Bioprocess factors affecting glycoprotein oligosaccharide structure. Developments in Biological Standardization, 76, 95-104. Review.
4. Sheeley, D.M., Merrill, B.M. and Taylor, L.C. (1997) Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose. Analytical Biochemistry, 247, 102-110.
5. Kagawa, Y., Takasaki, S., Utsumi, J., Hosoi, K., Shimizu, H., Kochibe, N. and Kobata, A. (1988) Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells. The Journal of Biological Chemistry, 263, 17508-17515.
6. Jenkins, N. and Curling, E.M. (1994) Glycosylation of recombinant proteins: problems and prospects. Enzyme and Microbial Technology, 16, 354-364.
7. Gawlitzek, M., Valley, U., Nimtz, M., Wagner, R. and Conradt, H.S. (1995) Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions. Journal of Biotechnology, 42, 117-131.
8. Schweikart, F., Jones, R., Jaton, J.C. and Hughes, G.J. (1999) Rapid structural characterisation of a murine monoclonal IgA alpha chain: heterogeneity in the oligosaccharide structures at a specific site in samples produced in different bioreactor systems. Journal of Biotechnology, 69, 191-201.
9. Jenkins, N., Parekh, R.B. and James, D.C. (1996) Getting the glycosylation right: implications for the biotechnology industry. Nature Biotechnology, 14, 975-981.
10. Reuter, G. and Gabius, H.J. (1999) Eukaryotic glycosylation: whim of nature or multipurpose tool? Cellular and Molecular Life Sciences, 55, 368-422. Review.
11. Restelli, V. and Butler, M. (2002) The effect of cell culture parameters on protein glycosylation, in Glycosylation, vol 3 (ed. M. Al-Rubeai), Kluwer, Dordrecht, pp. 61-92.
12. Wurm, F.M. (2004) Production of recombinant protein therapeutics in cultivated mammalian cells. Nature Biotechnology, 22, 1393-1398.
13. Andersen, D.C. and Krummen, L. (2002) Recombinant protein expression for therapeutic applications. Current Opinion in Biotechnology, 13, 117-123.
14. Gasser, C.S., Simonsen, C.C., Schilling, J.W. and Schimke, R.T. (1982) Expression of abbreviated mouse dihydrofolate reductase genes in, cultured hamster cells. Proceedings of the National Academy of Sciences of the United States of America, 79, 6522-6526.
15. Lucas, B.K., Giere, L.M., DeMarco, R.A., Shen, A., Chisholm, V. and Crowley, C.W. (1996) High-level production of recombinant proteins in CHO cells using a dicistronic DHFR intron expression vector. Nucleic Acids Research, 24, 1774-1779.
16. Bebbington, C.R., Renner, G., Thomson, S., King, D., Abrams, D. and Yarranton, G.T. (1992) High-level expression of a recombinant antibody from myeloma cells, using a glutamine synthetase gene as an amplifiable selectable marker. Bio/Technology (Nature Publishing Company), 10, 169-175.
17. Rudd, P.M. and Dwek, R.A. (1997) Glycosylation: heterogeneity and the 3D structure of proteins. Critical Reviews in Biochemistry and Molecular Biology, 32, 1-100.
18. Raju, T.S., Briggs, J.B., Borge, S.M. and Jones, A.J. (2000) Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics. Glycobiology, 10, 477-486.
19. Patnaik, S.K. and Stanley, P. (2006) Lectinresistant CHO glycosylation mutants. Methods in Enzymology. 2006, 416, 159-182. Review.
20. Sasaki, H., Bothner, B., Dell, A. and Fukuda, M. (1987) Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. The Journal of Biological Chemistry, 262 (25), 12059-12076.
21. Howard, D.R., Fukuda, M., Fukuda, M.N. and Stanley, P. (1987) The GDP-fucose:Nacetylglucosaminide 3-alpha-Lfucosyltransferases of LEC11 and LEC12 Chinese hamster ovary mutants exhibit novel specificities for glycolipid substrates. The Journal of Biological Chemistry, 262 (35), 16830-16837.
22. Backstrom, M., Link, T., Olson, F.J., Karlsson, H., Graham, R., Picco, G., Burchell, J., Taylor-Papadimitriou, J., Noll, T. and Hansson, G.C. (2003) Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. The Biochemical Journal, 376, 677-686.
23. Prati, E.G., Matasci, M., Suter, T.B., Dinter, A., Sburlati, A.R. and Bailey, J.E. (2000) Engineering of coordinated up-and down-regulation of two glycosyltransferases of the O-glycosylation pathway in Chinese hamster ovary (CHO) cells. Biotechnology and Bioengineering, 68 (3), 239-244.
24. Shelikoff, M., Sinskey, A.J. and Stephanopoulos, G. (1994) The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin. Cytotechnology, 15, 195-208.
25. Allen, S. Naim, H.Y. Bulleid, N.J. 1995 Intracellular folding of tissue-type plasminogen activator. Effects of disulfide bond formation on N-linked glycosylation and, secretion The Journal of Biological Chemistry, 270, 4797-4804.
26. Andersen, D.C. Bridges, T. Gawlitzek, M. Hoy, C. 2000 Multiple cell culture factors can affect the glycosylation of Asn-184 in CHO-produced tissue-type plasminogen activator. Biotechnology and Bioengineering, 70, 25-31.
27. Wang, W.C., Lee, N., Aoki, D., Fukuda, M.N. and Fukuda, M. (1991) The poly-Nacetyllactosamines attached to lysosomal membrane glycoproteins are increased by the prolonged association with the Golgi complex. The Journal of Biological Chemistry, 266, 23185-23190.
28. Nabi, I.R. and Dennis, J.W. (1998) The extent of polylactosamine glycosylation of MDCK LAMP-2 is determined by its Golgi residence time. Glycobiology, 8, 947-953.
29. Lau, K.S., Partridge, E.A., Grigorian, A., Silvescu, C.I., Reinhold, V.N., Demetriou, M., Dennis, J.W. (2007) Complex Nglycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell, 129(1): 123-34.
30. Butler, M., Quelhas, D., Critchley, A.J., Carchon, H., Hebestreit, H.F., Hibbert, R.G., Vilarinho, L., Teles, E., Matthijs, G., Schollen Argibay, P., Harvey, D.J., Dwek, R.A., Jaeken, J. and Rudd, P.M. (2003) Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific enzyme defect and, coupled with proteomics, provides an insight into pathogenesis. Glycobiology, 13, 601-622.
31. Umana, P. and Bailey, J.E. (1997) A mathematical model of N-linked glycoform biosynthesis. Biotechnology and Bioengineering, 55, 890-908.
32. Sburlati, A.R., Umana, P., Prati, E.G. and Bailey, J.E. (1998) Synthesis of bisected glycoforms of recombinant IFN-beta by overexpression of beta-1.4-Nacetylglucosaminyltransferase III in Chinese hamster ovary cells. Biotechnology Progress, 14 (2), 189-192.
33. Umana, P., Jean-Mairet, J., Moudry, R., Amstutz, H. and Bailey, J.E. (1999) Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity. Nature Biotechnology, 17, 176-180.
34. Hirschberg, C.B. (2001) Golgi nucleotide sugar transport and leukocyte adhesion deficiency II. The Journal of Clinical Investigation, 108, 3-6.
35. Freeze, H.H.J. (2002) Sweet solution: sugars to the rescue. Cell Biology, 158, 615-616.
36. Narhi, L.O. Arakawa, T. Aoki, K.H. Elmore, R. Rohde, M.F. Boone, T. Strickland, T.W. 1991 The effect of carbohydrate on the structure and stability of erythropoietin The Journal of Biological Chemistry, 266, 23022-23026.
37. Noda, K. Miyoshi, E. Uozumi, N.Gao, C.X. Suzuki, K. Hayashi, N. Hori, M. Taniguchi, N. 1998 High expression of alpha-1-6 fucosyltransferase during rat hepatocarcinogenesis. International Journal of Cancer, 75, 444-450.
38. Voynow, J.A., Kaiser, R.S., Scanlin, T.F. and Glick, M.C. (1991) Purification and characterization of GDP-L-fucose-Nacetyl beta-D-glucosaminide alpha 1-6 fucosyltransferase from cultured human skin fibroblasts. Requirement of a specific biantennary oligosaccharide as substrate. The Journal of Biological Chemistry, 266, 21572-21577.
39. Breton, C., Oriol, R. and Imberty, A. (1998) Conserved structural features in eukaryotic and prokaryotic fucosyltransferases. Glycobiology, 8, 87-94.
40. Srikrishna, G., Varki, N.M., Newell, P.C., Varki, A. and Freeze, H.H. (1997) An IgG monoclonal antibody against Dictyostelium discoideum glycoproteins specifically recognizes Fucalpha1.6GlcNAcbeta in the core of N-linked glycans. Localized expression of core-fucosylated glycoconjugates in human tissues. The Journal of Biological Chemistry, 272, 25743-25752.
41. Miyoshi, E., Noda, K., Ko, J.H., Ekuni, A., Kitada, T., Uozumi, N., Ikeda, Y., Matsuura, N., Sasaki, Y., Hayashi, N., Hori, M. and Taniguchi, N. (1999) Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice. Cancer Research, 59, 2237-2243.
42. Stubbs, H.J., Lih, J.J., Gustafson, T.L. and Rice, K.G. (1996) Influence of core fucosylation on the flexibility of a biantennary N-linked oligosaccharide. Biochemistry, 35, 937-947.
43. Wang,W., Li,W., Ikeda, Y., Miyagawa, J.I., Taniguchi, M., Miyoshi, E., Sheng, Y., Ekuni, A., Ko, J.H., Yamamoto, Y., Sugimoto,T.,Yamashita, S.,Matsuzawa,Y., Grabowski,G.A.,Honke,K.andTaniguchi, N. (2001) Ectopic expression of alpha 1,6 fucosyltransferase inmice causes steatosis in the liver and kidney, accompanied by a modification of lysosomal acid lipase. Glycobiology, 11, 165-174.
44. Sturla, L., Etzioni, A., Bisso, A., Zanardi, D., De Flora, G., Silengo, L., De Flora, A. and Tonetti, M. (1998) Defective intracellular activity of GDP-D-mannose-4,6-dehydratase in leukocyte adhesion deficiency type II syndrome. FEBS Letters, 429, 274-278.
45. Tonetti, M., Sturla, L., Bisso, A., Benatti, U. and De Flora, A. (1996) Synthesis of GDP-L-fucose by the human FX protein. The Journal of Biological Chemistry, 271, 27274-27279.
46. Ohyama, C., Smith, P.L., Angata, K., Fukuda, M.N., Lowe, J.B. and Fukuda, M. (1998) Molecular cloning and expression of GDP-D-mannose-4,6-dehydratase, a key enzyme for fucose metabolism defective in Lec13 cells. The Journal of Biological Chemistry, 273, 14582-14587.
47. Yamashita, K., Koide, N., Endo, T., Iwaki, Y. and Kobata, A. (1989) Altered glycosylation of serum transferring of patients with hepatocellular carcinoma. The Journal of Biological Chemistry, 264, 2415-2423.
48. Uozumi, N., Yanagidani, S., Miyoshi, E., Ihara, Y., Sakuma, T., Gao, C.X., Teshima, T., Fujii, S., Shiba, T. and Taniguchi, N. (1996) Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1-6 fucosyltransferase. The Journal of Biological Chemistry, 271, 27810-27817.
49. Saitoh, A., Aoyagi, Y. and Asakura, H. (1993) Structural analysis on the sugar chains of human alpha 1-antitrypsin: presence of fucosylated biantennary glycan in hepatocellular carcinoma. Archives of Biochemistry and Biophysics, 303, 281-287.
50. Takahashi, T., Ikeda, Y., Miyoshi, E., Yaginuma, Y., Ishikawa, M. and Taniguchi, N. (2000) Alpha1, 6fucosyltransferase is highly and specifically expressed in human, ovarian serous adenocarcinomas. International Journal of Cancer, 88, 914-919.
51. Yanagidani, S., Uozumi, N., Ihara, Y., Miyoshi, E., Yamaguchi, N. and Taniguchi, N. (1997) Purification and cDNA cloning of GDP-L-Fuc:N-acetylbeta-D-glucosaminide:alpha1-6 fucosyltransferase (alpha1-6 FucT) from human gastric cancer MKN45 cells. Journal of Biochemistry, 121, 626-632.
52. Barasch, J., Kiss, B., Prince, A., Saiman, L., Gruenert, D. and al-Awqati, Q. (1991) Defective acidification of intracellular organelles in cystic fibrosis. Nature, 352 (6330), 70-73.
53. Sears, P. and Wong, C.H. (1998) Enzyme action in glycoprotein synthesis. Cellular and Molecular Life Sciences, 54, 223-252.
54. Longmore, G.D. and Schachter, H. (1982) Product-identification and substratespecificity studies of the GDP-L-fucose: 2-acetamido-2-deoxy-beta-D-glucoside (FUC goes to Asn-linked GlcNAc) 6-alpha-L-fucosyltransferase in a Golgirich fraction from porcine liver. Carbohydrate Research, 100, 365-392.
55. Weiss, P. and Ashwell, G. (1989) The asialoglycoprotein receptor: properties and modulation by ligand. Progress in Clinical and Biological Research, 300, 169-184.
56. Rijcken, P.W.R., Overdijk, B., Van den Eijnden, D.H. and Ferwerda, W. (1995) The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. The Biochemical Journal, 305, 865-870.
57. Seppala, R., Lehto, V.P. and Gahl, W.A. (1999) Mutations in the human UDP-Nacetylglucosamine 2-epimerase gene define the disease sialuria and the allosteric site of the enzyme. American Journal of Human Genetics, 64, 1563-1569.
58. Valley, U., Nimtz, M., Conradt, H.S. and Wagner, R. (1999) Incorporation of ammonium into intracellular UDPactivated N-acetylhexosamines and into carbohydrate structures in glycoproteins. Biotechnology and Bioengineering, 64 (4), 401-417.
59. Gu, X. and Wang, D.I. (1998) Improvement of interferon-gamma sialylation in Chinese hamster ovary cell culture by feeding of N-acetylmannosamine. Biotechnology and Bioengineering, 58 (6), 642-648.
60. Baker, K.N., Rendall, M.H., Hills, A.E., Hoare, M., Freedman, R.B. and James, D.C. (2001) Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnology and Bioengineering, 73, 188-202.
61. Follstad, B.D. (2004) A method for increasing glycoprotein sialylation in mammalian cells. Cell Culture Engineering IX Poster, Cancun Mexico.
62. Jones, M.B., Teng, H., Rhee, J.K., Lahar, N., Baskaran, G. and Yarema, K.J. (2004) Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids. Biotechnology and Bioengineering, 85 (4), 394-405.
63. Weikert, S., Papac, D., Briggs, J., Cowfer, D., Tom, S., Gawlitzek, M., Lofgren, J., Mehta, S., Chisholm, V., Modi, N., Eppler, S., Carroll, K., Chamow, S., Peers, D., Berman, P. and Krummen, L. (1999) Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins. Nature Biotechnology, 17, 1116-1121.
64. Angata, T. and Varki, A. (2002) Chemical diversity in the sialic acids and related a-keto acids: An evolutionary perspective. Chemical Reviews, 102, 439-469.
65. Dawson, G., Moskal, J.R. and Dawson, S.A. (2004) Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNActransferase genes into human, glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death. Journal of Neurochemistry, 89 (6), 1436-1444.
66. Takeuchi, M., Takasaki, S., Miyazaki, H., Kato, T., Hoshi, S., Kochibe, N. and Kobata, A. (1988) Comparative study of the asparagine-linked sugar chains of human erythropoietins purified from urine and the culture medium of recombinant Chinese hamster ovary cells. The Journal of Biological Chemistry, 263, 3657-3663.
67. Grabenhorst, E., Hoffmann, A., Nimtz, M., Zettlmeissl, G. and Conradt, H.S. (1995) Construction of stable BHK-21 cells coexpressing human secretory glycoprotein and human Gal (b1-4) GlcNAc-R a2,6-sialyltransferase. European Journal of Biochemistry, 232, 718-725.
68. Bragonzi, A., Distefano, G., Buckberry, L.D., Acerbis, G., Foglieni, C., Lamotte, D., Campi, G., Marc, A., Soria, M.R., Jenkins, N. and Monaco, L. (2000) A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins. Biochimica et Biophysica Acta, 1474 (3), 273-282.
69. Wormald, M.R., Rudd, P.M.,Harvey, D.J., Chang, S.C., Scragg, I.G. and Dwek, R.A. (1997) Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides. Biochemistry, 36, 1370-1380.
70. Noguchi, A., Mukuria, C.J., Suzuki, E. and Naiki, M. (1995) Immunogenicity of N-glycolylneuraminic acid-containing carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Journal of Biochemistry, 117 (1), 59-62.
71. Hokke, C.H., Bergwerff, A.A., Van Dedem, G.W., Kamerling, J.P. and Vliegenthart, J.F. (1995) Structural analysis of the sialylated N-and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N,-acetyllactosamine units. European Journal of Biochemistry, 228, 981-1008.
72. Curling, E.M., Hayter, P.M., Baines, A.J., Bull, A.T., Gull, K., Strange, P.G. and Jenkins, N. (1990) Recombinant human interferon-gamma. Differences in glycosylation and proteolytic processing lead to heterogeneity in batch culture. The Biochemical Journal, 272, 333-337.
73. Hooker, A.D., Green, N.H., Baines, A.J., Bull, A.T., Jenkins, N., Strange, P.G. and James, D.C. (1999) Constraints on the transport and glycosylation of recombinant IFN-gamma in Chinese hamster ovary and insect cells. Biotechnol Bioeng, 63 (5), 559-572.
74. Hayter, P.M., Curling, E.M.A., Baines, A.J., Jenkins, N., Salmon, I., Strange, P.G., Tong, J.M. and Bull, A.T. (1992) Glucose-limited chemostat culture of Chinese hamster ovary cells producing recombinant human interferon. Biotechnology and Bioengineering, 39, 327-335.
75. Nyberg, G.B., Balcarcel, R.R., Follstad, B.D., Stephanopoulos, G. and Wang, D.I. (1999) Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells. Biotechnology and Bioengineering, 62, 336-347.
76. Kiss, R., Magreta, P., Gray, B., Stupp, T., Kaneshiro, S. and Ryll, T. (1999) Control of Glycosylation by environmental Manipulations in CHO Cell Cultures, American Chemical Society Division of Biochemical Technology, Anaheim, CA.
77. Xie, L. and Wang, D.I. (1997) Integrated approaches to the design of media and feeding strategies for fed-batch cultures of animal cells. Trends in Biotechnology, 15, 109-113.
78. Chee Furng Wong, D., Tin Kam Wong, K., Tang Goh, L., Kiat Heng, C. and Gek Sim Yap, M. (2005) Impact of dynamic online fed-batch strategies on metabolism, productivity and N-glycosylation quality in CHO cell cultures. Biotechnology and Bioengineering, 89, 164-177.
79. Stark, N.J. and Heath, E.C. (1979) Glucose-dependent glycosylation of secretory glycoprotein in mouse myeloma cells. Archives of Biochemistry and Biophysics, 192, 599-609.
80. Davidson, S.K. and Hunt, L.A. (1985) Sindbis virus glycoproteins are abnormally glycosylated in Chinese hamster ovary cells deprived of glucose. The Journal of General Virology, 66, 1457-1468.
81. Rearick, J.I.,Chapman, A. andKornfeld, S. (1981) Glucose starvation alters lipidlinked oligosaccharide biosynthesis in Chinese hamster ovary cells. The Journal of Biological Chemistry, 256, 6255-6261.
82. Tachibana, H., Kim, J. and Shivahata, S. (1997) Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetyl glucosamine-supplemented hybridoms cultures. Cytotechnol, 23, 151-159.
83. Gawlitzek, M., Valley, U. and Wagner, R. (1998) Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells. Biotechnology and Bioengineering, 57, 518-528.
84. Grammatikos, S.I., Valley, U., Nimtz, M., Conradt, H.S. and Wagner, R. (1998) Intracellular UDP-N-acetylhexosamine pool affects N-glycan complexity: a mechanism of ammonium action on protein glycosylation. Biotechnology Progress, 14, 410-419.
85. Pels Rijcken, W.R., Overdijk, B., Van den Eijnden, D.H. and Ferwerda, W. (1995) The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. The Biochemical Journal, 305, 865-870.
86. Clark, K.J., Griffiths, J., Bailey, K.M. and Harcum, S.W. (2005) Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap. Biotechnology and Bioengineering, 90, 568-577.
87. Butler, M. and Spier, R.E. (1984) The effects of glutamine utilisation and ammonia production on the growth of BHK cells in microcarrier cultures. Journal of Biotechnology, 1, 187-196.
88. Doyle, C. and Butler, M. (1990) The effect of pH on the toxicity of ammonia to a murine hybridoma. Journal of Biotechnology, 15, 91-100.
89. Andersen, D.C. and Goochee, C.F. (1994) The effect of cell-culture conditions on the oligosaccharide structures of secreted glycoproteins. Current Opinion in Biotechnology, 5, 546-549.
90. Zanghi, J.A., Mendoza, T.P., Knop, R.H. and Miller, W.M. (1998) Ammonia inhibits neural cell adhesion molecule polysialylation in Chinese hamster ovary and small cell lung cancer cells. Journal of Cellular Physiology, 177, 248-263.
91. Yang, M. and Butler, M. (2000) Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnology and Bioengineering, 68, 370-380.
92. Andersen, D.C. and Goochee, C.F. (1995) The effect of ammonia on the O-linked glycosylation of granulocyte colonystimulating factor produced by Chinese hamster ovary cells. Biotechnology and Bioengineering, 47, 96-105.
93. Rothman, R.J., Warren, L., Vliegenthart, J.F. and Hard, K.J. (1989) Clonal analysis of the glycosylation of immunoglobulinG secreted by murine hybridomas. Biochemistry, 28, 1377-1384.
94. Borys, M.C., Linzer, D.I. and Papoutsakis, E.T. (1993) Culture pH affects expression rates and glycosylation of recombinant, mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Bio/Technology (Nature Publishing Company) 11, 720-724.
95. Jan, D.C., Petch, D.A., Huzel, N. and Butler, M. (1997) The effect of dissolved oxygen on the metabolic profile of a murine hybridoma grown in serum-free medium in continuous cultures. Biotechnology and Biochemistry, 54, 153-164.
96. Heidemann, R., Lutkemeyer, D., Buntemeyer, H. and Lehmann, J. (1998) Effects of dissolved oxygen levels and the role of extra-and intracellular amino acid concentration upon the metabolism of mammalian cell lines during batch and continuous cultures. Cytotechnology, 26, 185-197.
97. Chotigeat, W., Watanapokasin, Y.,Mahler, S. and Gray, P.P. (1994) Role of environmental conditions on the expression levels, glycoform pattern and levels of sialyltransferase for hFSH produced by recombinant CHO cells. Cytotechnology, 15, 217-221.
98. Kunkel, J.P., Jan, D.C., Jamieson, J.C. and Butler, M. (1998) Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. Journal of Biotechnology, 62, 55-71.
99. Kunkel, J.P., Yan, W.Y., Butler, M. and Jamieson, J.C. (2003) Decreased monoclonal IgG1 galactosylation at reduced dissolved oxygen concentration is not a result of lowered galactosyltransferase activity in vitro. Society for Glycobiology Meeting, San Diego, CA, Glycobiology 13, pp. 875.
100. Rademacher, T.W., Jaques, A. and Williams, P.J. (1996) The defining characteristics of immunoglobulin glycosylation, in Abnormalities of IgG Glycosylation and Immunological Disorders (eds D.A. Isenberg and T.W. Rademacher), John Wiley & Sons, Inc, New York, pp. 1-44.
101. Shriver, Z., Raguram, S. and Sasisekharan, R. (2004) Glycomics: A pathway to a class of new and improved therapeutics. Nature Reviews Drug Discovery, 3, 863-873.
102. Erbayraktar, S., Grasso, G., Sfacteria, A., Xie, Q.W., Coleman, T., Kreilgaard, M., Torup, L., Sager, T., Erbayraktar, Z., Gokmen, N., Yilmaz, O.,Ghezzi, P., Villa, P., Fratelli, M., Casagrande, S., Leist, M., Helboe, L., Gerwein, J., Christensen, S., Geist, M.A., Pedersen, L.O., Cerami-Hand, C., Wuerth, J.P., Cerami, A. and Brines, M. (2003) Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proceedings of the National Academy of Sciences of the United States of America, 100, 6741-6746.
103. Egrie, J.C., Dwyer, E., Browne, J.K., Hitz, A. and Lykos, M.A. (2003) Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Experimental Hematology, 31, 290-299.
104. Perlman, S., van den Hazel, B., Christiansen, J., Gram-Nielsen, S., Jeppesen, C.B., Andersen, K.V., Halkier, T., Okkels, S. and Schambye, H.T. (2003) Glycosylation of an N-terminal extension prolongs the half-life and increases the in vivo activity of follicle stimulating hormone. The Journal of Clinical Endocrinology and Metabolism, 88, 3227-3235.
105. Thotakura, N.R., Desai, R.K., Bates, L.G., Cole, E.S., Pratt, B.M. and Weintraub, B.D. (1991) Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology, 128, 341-348.
106. Davies, J., Jiang, L., Pan, L.Z., LaBarre, M.J., Anderson, D. and Reff, M. (2001) Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Biotechnology and Bioengineering, 74, 288-294.
107. Shields, R.L., Lai, J., Keck, R., O'Connell, L.Y., Hong, K., Meng, Y.G., Weikert, S.H. and Presta, L.G. (2002) Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. The Journal of Biological Chemistry, 277, 26733-26740.
108. Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., Hanai, N. and Shitara, K. (2003) The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. The Journal of Biological Chemistry, 278, 3466-3473.
109. Okazaki, A., Shoji-Hosaka, E., Nakamura, K., Wakitani, M., Uchida, K., Kakita, S., Tsumoto, K., Kumagai, I. and Shitara, K. (2004) Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. Journal of Molecular Biology, 336, 1239-1249.
110. Shen, A., Ng, D., Joly, J., Snedecor, B., Lu, Y., Meng, G., Nakamura, G. and Krummen, L. (2007) Metabolic engineering to control glycosylation, in Cell Culture and Upstream Processing (ed. M. Butler), Taylor & Francis.
111. Elbein, A.D., Tropea, J.E., Mitchell, M. and Kaushal, G.P. (1990) Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. The Journal of Biological Chemistry, 265 (26), 15599-15605.
112. Zhou, Q., Shankara, S., Roy, A., Qiu, H., Estes, S., McVie-Wylie, A., Culm-Merdek, K., Park, A., Pan, C. and Edmunds, T. (2007) Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function. Biotechnology and Bioengineering, 99 (3), 652-665.
113. Raju, T.S., Briggs, J.B., Chamow, S.M., Winkler, M.E. and Jones, A.J. (2001) Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues. Biochemistry, 40, 8868-8876.